# Posts by BiotechNews.io (page 3 of 5)

110 posts.

- [Zymeworks Announces $200 Million Share Repurchase Authorization](https://biotechnews.io/news/zymeworks-announces-200-million-share-repurchase-authorization.md) (2026-11-16)
- [Vivani Medical Announces Private Placement Equity Financing](https://biotechnews.io/news/vivani-medical-announces-private-placement-equity-financing.md) (2026-11-16)
- [FOR INVESTORS AND FINANCIAL AND BUSINESS MEDIA ONLY  Renaissance Pharma secures FDA Breakthrough Therapy Designation for daretabart in newly diagnosed high-risk neuroblastoma](https://biotechnews.io/news/for-investors-and-financial-and-business-media-only-renaissance-pharma-secures-fda-breakth.md) (2026-11-16)
- [Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results](https://biotechnews.io/news/cocrystal-pharma-provides-business-update-and-reports-third-quarter-2026-financial-results.md) (2026-11-15)
- [Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biotechnews.io/news/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md) (2026-11-14)
- [Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biotechnews.io/news/korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md) (2026-11-13)
- [Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update](https://biotechnews.io/news/indaptus-therapeutics-reports-third-quarter-2026-financial-results-and-provides-corporate.md) (2026-11-13)
- [4DMT Announces New Employment Inducement Grants](https://biotechnews.io/news/4dmt-announces-new-employment-inducement-grants.md) (2026-11-13)
- [Kura Oncology to Participate in Two Investor Conferences in November](https://biotechnews.io/news/kura-oncology-to-participate-in-two-investor-conferences-in-november.md) (2026-11-13)
- [Global AI Protein Design Market Report 2026-2033 | Generative AI Fuels 35.3% CAGR and a $20.9 Billion Biologics Opportunity by 2033](https://biotechnews.io/news/global-ai-protein-design-market-report-2026-2033-generative-ai-fuels-35-3-cagr-and-a-20-9.md) (2026-11-13)
- [From Boston to Portland: QuTEM and OHSU Give West Coast Advanced Therapy Developers a Direct Path from R&D to GMP](https://biotechnews.io/news/from-boston-to-portland-qutem-and-ohsu-give-west-coast-advanced-therapy-developers-a-direc.md) (2026-11-13)
- [COSCIENS Biopharma Inc. Reports Q3 2026 Results and Provides Update On Convertible Debenture Offering](https://biotechnews.io/news/cosciens-biopharma-inc-reports-q3-2026-results-and-provides-update-on-convertible-debentur.md) (2026-11-13)
- [Biorisk Management Service Market Size to Reach USD 4.91 Billion by 2033, Growing at 11.4% CAGR as Regulatory Compliance and Risk Assessment Demand Accelerates: Verified Market Research](https://biotechnews.io/news/biorisk-management-service-market-size-to-reach-usd-4-91-billion-by-2033-growing-at-11-4-c.md) (2026-11-13)
- [Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance](https://biotechnews.io/news/allarity-therapeutics-reports-third-quarter-2026-results-and-provides-full-year-2026-finan.md) (2026-11-13)
- [Surrozen Announces Pricing of $60 Million Underwritten Offering of Common Stock](https://biotechnews.io/news/surrozen-announces-pricing-of-60-million-underwritten-offering-of-common-stock.md) (2026-11-13)
- [Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data](https://biotechnews.io/news/milestone-pharmaceuticals-reports-third-quarter-2026-financial-results-and-announces-cost.md) (2026-11-13)
- [Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up](https://biotechnews.io/news/quantum-biopharma-achieve-91-increase-in-shareholder-equity-and-liquidity-in-q3-2026-as-lu.md) (2026-11-13)
- [Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants](https://biotechnews.io/news/rezolute-announces-pricing-of-approximately-100-million-underwritten-offering-of-common-st.md) (2026-11-13)
- [Windward Bio Announces Pricing of Initial Public Offering](https://biotechnews.io/news/windward-bio-announces-pricing-of-initial-public-offering.md) (2026-11-12)
- [HYTN Shareholders Approve Spin Out of Peptide Development Labs Inc.](https://biotechnews.io/news/hytn-shareholders-approve-spin-out-of-peptide-development-labs-inc.md) (2026-11-12)
- [Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update](https://biotechnews.io/news/longeveron-announces-2026-third-quarter-financial-results-and-provides-business-update.md) (2026-11-12)
- [Voting Rights and Shares Capital of the Company](https://biotechnews.io/news/voting-rights-and-shares-capital-of-the-company.md) (2026-11-12)
- [Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biotechnews.io/news/shattuck-labs-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md) (2026-11-12)
- [Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments](https://biotechnews.io/news/dyadic-announces-third-quarter-2026-financial-results-and-recent-developments.md) (2026-11-12)

[Newer](https://biotechnews.io/author/biotechnews-io/page/2.md) · [Older](https://biotechnews.io/author/biotechnews-io/page/4.md)